Home/Filings/4/0000950138-11-000609
4//SEC Filing

PYXIS INNOVATIONS INC 4

Accession 0000950138-11-000609

CIK 0001037649other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 4:27 PM ET

Size

11.2 KB

Accession

0000950138-11-000609

Insider Transaction Report

Form 4
Period: 2011-11-09
ALTICOR INC
10% Owner
Transactions
  • Purchase

    Convertible Promissory Note

    2008-06-1030,454,965 total
    Exercise: $5.68Common Stock (352,219 underlying)
Transactions
  • Purchase

    Convertible Promissory Note

    2008-06-1030,454,965 total
    Exercise: $5.68Common Stock (352,219 underlying)
Transactions
  • Purchase

    Convertible Promissory Note

    2008-06-1030,454,965 total
    Exercise: $5.68Common Stock (352,219 underlying)
Transactions
  • Purchase

    Convertible Promissory Note

    2008-06-1030,454,965 total
    Exercise: $5.68Common Stock (352,219 underlying)
Footnotes (2)
  • [F1]On November 9, 2011, Pyxis was issued a convertible promissory note by the Issuer with an original principal amount of $2,000,000. The maturity date of this convertible promissory note is June 30, 2012. The original principal amount of the convertible promissory note, plus accrued interest thereon, is convertible into the Issuer's common stock at any time at the option of Pyxis. The number of shares of common stock into which the balance of this convertible promissory note may be converted is to be determined by dividing the aggregate principal amount to be converted, together with all accrued interest to the date of conversion, by $5.6783. As of November 9, 2011, the convertible promissory note would have been convertible into 352,219 shares of the Issuer's common stock.
  • [F2]This amount includes 5,000,000 shares of the Issuer's Series A preferred stock held by Pyxis, which are convertible into 28,160,200 shares of common stock. As of November 9, 2011, Pyxis holds six convertible promissory notes issued by the Issuer in the aggregate principal amount of $13,000,000. Taking into account accrued interest to date, these notes are currently convertible into 2,294,765 shares of common stock of Pyxis.

Issuer

INTERLEUKIN GENETICS INC

CIK 0001037649

Entity typeother

Related Parties

1
  • filerCIK 0001221575

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 4:27 PM ET
Size
11.2 KB